Huijun Lei
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
BRCA1/2 variant landscape and clinical correlates in high-risk breast cancer patients from Eastern China.
Journal: Frontiers in oncology
Published: January 21, 2026
Clinical predictors of BRCA1/2 P/LP variants for high-risk breast cancer patients in China: HBRCA-risk prediction.
Journal: Frontiers in oncology
Published: January 02, 2026
Global prevalence and ethnic variation of pathogenic BRCA1/2 variants in breast cancer: a systematic review and meta-analysis.
Journal: Journal of translational medicine
Published: October 07, 2025
CRISPR/Cas9 genome engineering in PDAC: From preclinical studies to translation and clinical research.
Journal: Seminars in cancer biology
Published: February 03, 2025
Informatics strategies for early detection and risk mitigation in pancreatic cancer patients.
Journal: Neoplasia (New York, N.Y.)
Published: November 07, 2024
Breast Cancer: Molecular Pathogenesis, Targeted Therapy, Screening, and Prevention.
Journal: MedComm
Published: October 31, 2024
Pathogenic variants in human DNA damage repair genes mostly arose in recent human history.
Journal: BMC cancer
Published: September 21, 2023
Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes.
Journal: Human genomics
Published: May 27, 2023
Use of Period Analysis to Timely Assess Five-Year Relative Survival for Patients with Ovarian Cancer from Taizhou, Eastern China.
Journal: Journal of clinical medicine
Published: January 13, 2023
Evolutionary Origin of MUTYH Germline Pathogenic Variations in Modern Humans.
Journal: Biomolecules
Published: December 07, 2022
Last Updated: 09/26/2026